ANNX.ST

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Biotechnology

Analyst estimates (consensus)

Year	Est. revenue	Growth	Est. EPS	EPS range	Fwd P/E	# Analysts
2026	$46M	-11.8%	$0.00	$0.00–$0.00	—	0
2027	$33M	-28.5%	$0.00	$0.00–$0.00	—	0

Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep

DCF fair valuemodel estimate

Intrinsic value

$3.77

Price

$12.80

Implied downside

-71%

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
ANNX.STAnnexin Pharmaceuticals AB	$12.70	-0.78%	$91M	—
ALZ.STAlzinova AB (publ)	$0.46	-1.18%	$47M	—
BIOWKS.STBio-Works Technologies AB (publ)	$3.21	+1.90%	$266M	—
CLS-B.STClinical Laserthermia Systems AB (publ)	$1.89	-0.42%	$60M	—
ERMA.STEnorama Pharma AB (publ)	$0.79	+4.47%	$59M	—
INIT.STInitiator Pharma A/S	$2.29	-2.55%

Source: Financial Modeling Prep · peers by sector/industry

Annexin Pharmaceuticals AB

Annexin Pharmaceuticals AB (publ), a clinical stage biotechnology company, develops drug candidates for the treatment of various cardiovascular diseases. It develops ANXV, a human recombinant protein and Annexin A5, natural protein that protects and repairs cells, as well as counteract unwanted inflammatory and immune cell reactions. Annexin Pharmaceuticals AB (publ) was incorporated in 2014 and is based in Stockholm, Sweden.

www.annexinpharma.com

Employees: 4
IPO / List date: Apr 19, 2017
HQ: SE

Held by traders on TradeandTell

No one on the platform currently holds ANNX.ST.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in ANNX.ST as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded ANNX.ST yet.